New implant offers hope for stubborn back pain sufferers

NCT ID NCT06909292

Completed Disease control Sponsor: Nevro Corp Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at a device called Nevro1, which is a titanium cage implanted in the sacroiliac joint to stabilize it and encourage bone fusion. Researchers wanted to see if it could safely reduce pain and improve function in 180 adults with chronic sacroiliac joint dysfunction. The main goals were pain relief, no serious side effects, and evidence of joint fusion at one and two years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Nevro1 sacroiliac transfixing and fusion system (a titanium implant with bone graft to stabilize the joint)
What this could lead to: If successful, this device could offer a safe, lasting option for people with chronic sacroiliac joint pain who haven't found relief from other treatments.
What could go wrong: This is a post-market study, so the device is already approved. However, results may not apply to everyone, and risks include implant-related complications or lack of pain relief.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SACROILIAC JOINT DYSFUNCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SACROILIAC JOINT DYSFUNCTION

Contacts and locations

Locations

AIRS Clinic

Lodi, California, 95240, United States
Advanced Spine and Pain Specialists

Spring, Texas, 77380, United States
Carolinas Pain Institute

Winston-Salem, North Carolina, 27103, United States
Michigan Orthopaedic Surgeons

Southfield, Michigan, 48033, United States
Procura Pain and Spine

The Woodlands, Texas, 77384, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.